Crystagen (20 mg Vial) Dosage Protocol
Quickstart Highlights
Crystagen (Glu-Asp-Pro) is a tripeptide bioregulator studied for immune system modulation and cellular regulation[1]. This synthetic peptide is designed to support immune function and has been investigated in research settings for its immunomodulatory properties[2]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard / Gradual Approach (3 mL = 6.67 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Week 1 | 1000 mcg (1 mg) | 15 units (0.15 mL) |
| Week 2 | 1500 mcg (1.5 mg) | 23 units (0.23 mL) |
| Weeks 3–12 | 2000 mcg (2 mg) | 30 units (0.30 mL) |
Frequency: Inject once daily subcutaneously. This schedule uses a 3.0 mL dilution to keep per-injection units ≥10 for accurate measuring. Research protocols typically utilize daily subcutaneous injections for systemic immune modulation[1][2]. Similar immunomodulatory peptides have been administered in daily injection courses in clinical settings[3].
Reconstitution Steps
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on an 8–16 week daily protocol with gradual titration.
- 8 weeks ≈ 6 vials
- 12 weeks ≈ 9 vials
- 16 weeks ≈ 12 vials
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
- 8 weeks (6 vials): 18 mL → 1 × 30 mL bottle (plan for second vial if exceeding 28 days)
- 12 weeks (9 vials): 27 mL → 2 × 30 mL bottles
- 16 weeks (12 vials): 36 mL → 2–3 × 30 mL bottles (replace after ~8 weeks for sterility)
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
- 16 weeks: 224 swabs → recommend 3 × 100-count boxes
Protocol Overview
Concise summary of the once-daily regimen.